Overview: Estradiol (E2) TestIntroduction: The Estradiol (E2) Test measures estradiol levels to assess hormonal imbalances, causing infertility or irregular periods. Aligned with 2023 Endocrine Society guidelines, it uses an immunoassay for high sensitivity, aiding in endocrine screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in endocrinology for patients with suspected hormonal disorders.
Other Names: E2 Assay, Estrogen Hormone Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: Estradiol testing began in the 1970s with hormone research. Immunoassays emerged in the 1980s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Diagnoses hormonal imbalances, guides treatment, and monitors estradiol levels in patients with infertility or irregular periods.
Test Parameters: 1. Estradiol
Pretest Condition: Fasting for 10-12 hours required to stabilize hormone levels. Collect serum or plasma in the morning. Report symptoms like infertility or irregular periods, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document infertility, irregular periods, or history of hormonal disorders (e.g., PCOS). Include current medications, especially hormonal therapies.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for hormonal therapy.
Procedural Considerations: Uses an immunoassay to measure estradiol levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Non-fasting, stress, or medications can affect results. Hemolysis may degrade samples.
Clinical Significance: Abnormal estradiol levels suggest hormonal imbalances, prompting treatment (e.g., hormone therapy). Normal levels may require further testing.
Specialist Consultation: Consult an endocrinologist or reproductive specialist for result interpretation.
Additional Supporting Tests: FSH, LH, or pelvic ultrasound to confirm hormonal disorders.
Test Limitations: Results may be affected by medications or stress. Clinical correlation is required.
References: Endocrine Society Hormone Guidelines, 2023; Journal of Clinical Endocrinology, Stanczyk FZ, 2022.
